Amy Rabourn
Treasurer bei OCUPHIRE PHARMA, INC.
Vermögen: 12 939 $ am 31.05.2024
Aktive Positionen von Amy Rabourn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OCUPHIRE PHARMA, INC. | Treasurer | - | - |
| Comptroller/Controller/Auditor | 11.11.2020 | - | |
| Finanzdirektor/CFO | 01.12.2019 | 12.02.2024 |
Karriereverlauf von Amy Rabourn
Ehemalige bekannte Positionen von Amy Rabourn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.12.2014 | 01.12.2019 |
Ausbildung von Amy Rabourn
| University of Michigan | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Director of Finance/CFO | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
- Börse
- Insiders
- Amy Rabourn
- Erfahrung
